-transparent.png){kind=logo}
Clinical improvement has been observed in myasthenia gravis patients treated by intravenous immunoglobulin (IVIg). In order to investigate the mechanism of action of these IVIg, we looked for an in vitro interaction between IVIg and the anti-acetylcholine receptor autoantibodies. Significant inhibition by IVIg of anti-acetylcholine receptor autoantibody activity from 30 MG sera was observed and binding of anti-acetylcholine receptor autoantibodies on IVIg was found for four of five myasthenia gravis sera. These observations suggest that IVIg contains Ig directly binding to and inhibiting pathogenic autoantibodies.
Related Publications
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
January 1982,
Journal of immunology (Baltimore, Md. : 1950),
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
January 2009,
Frontiers of neurology and neuroscience,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
May 1981,
Italian journal of neurological sciences,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
March 2014,
Rinsho byori. The Japanese journal of clinical pathology,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
November 1986,
Neurology,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
June 1987,
Journal of neurology,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
March 1993,
Neurology,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
January 1987,
Monographs in allergy,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
January 1977,
The New England journal of medicine,
R Liblau, and
P Gajdos, and
F A Bustarret, and
R el Habib, and
J F Bach, and
E Morel
July 1977,
The New England journal of medicine,
